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Biosensing-by-learning Direct Targeting Strategy for
Enhanced Tumor Sensitization
Yifan Chen∗, Muhammad Ali, Shaolong Shi, and U Kei Cheang
Abstract—Objective:We propose a novel iterative-optimization-
inspired direct targeting strategy (DTS) for smart nanosystems,
which harness swarms of externally manipulable nanoswimmers
assembled by magnetic nanoparticles (MNPs) for knowledge-
aided tumor sensitization and targeting. We aim to demonstrate
through computational experiments that the proposed DTS can
significantly enhance the accumulation of MNPs in the tumor
site, which serve as a contrast agent in various medical imaging
modalities, by using the shortest possible physiological routes and
with minimal systemic exposure.
Methods: The epicenter of a tumor corresponds to the global
maximum of an externally measurable objective function asso-
ciated with an in vivo tumor-triggered biophysical gradient; the
domain of the objective function is the tissue region at a high
risk of malignancy; swarms of externally controllable magnetic
nanoswimmers for tumor sensitization are modeled as the guess
inputs. The objective function may be resulted from a passive
phenomenon such as reduced blood flow or increased kurtosis
of microvasculature due to tumor angiogenesis; otherwise, the
objective function may involve an active phenomenon such as the
fibrin formed during the coagulation cascade activated by tumor-
targeted “activator” nanoparticles. Subsequently, the DTS can
be interpreted from the iterative optimization perspective: guess
inputs (i.e., swarms of nanoswimmers) are continuously updated
according to the gradient of the objective function in order to
find the optimum (i.e., tumor) by moving through the domain
(i.e., tissue under screening). Along this line of thought, we
propose the computational model based on the gradient descent
(GD) iterative method to describe the GD-inspired DTS, which
takes into account the realistic in vivo propagation scenario of
nanoswimmers.
Results: By means of computational experiments, we show
that the GD-inspired DTS yields higher probabilities of tumor
sensitization and more significant dose accumulation compared
to the “brute-force” search, which corresponds to the systemic
targeting scenario where drug nanoparticles attempt to target
a tumor by enumerating all possible pathways in the complex
vascular network.
Conclusion: The knowledge-aided DTS has potential to en-
hance the tumor sensitization and targeting performance remark-
ably by exploiting the externally measurable, tumor-triggered
biophysical gradients.
Significance: We believe that this work motivates a novel
biosensing-by-learning framework facilitated by externally ma-
nipulable, smart nanosystems.
Index Terms—Direct targeting strategy, biosensing-by-
learning, tumor-triggered biophysical gradients, externally
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I. INTRODUCTION
A. Background
1) Contrast-enhanced Medical Imaging: Magnetic reso-
nance imaging (MRI) is one of the standard procedures for
non-invasive clinical diagnosis of cancers due to its high soft
tissue contrast, spatial resolution, and penetration depth [1].
In addition, images are acquired without the use of ionizing
radiation or radio tracers that would cause harmful side-effects.
Contrast agents such as magnetic nanoparticles (MNPs) are
commonly used in MRI to provide better delineation between
healthy and diseased tissues [1]. Another promising modality
for cancer diagnosis and recurrence monitoring is microwave
imaging in view of its safety, mobility, and cost-effectiveness
[2]. For example, a number of operational microwave breast
imaging systems are already in clinical use [3]–[7] as re-
viewed in [8]. A major challenge faced by this approach is
the potentially small dielectric contrast between tumor and
its surrounding tissues, and between benign and cancerous
changes [9]–[11]. To overcome these issues, MNPs have also
been proposed as a contrast agent [12], [13]. However, the
current systemic targeted drug delivery route can only deliver
a very small fraction (< 2%) of the administered nanoparticles
to the precise site [14]. The main constraints include the
reliance on systemic circulation, the lack of a propelling force,
and the absence of a sensory-based displacement capability
[15].
2) Amplification of Tumor Homing through Externally Ma-
nipulable Nanoswimmers: Enhancing the diagnostic efficacy
of contrast agents necessitates the use of a direct targeting
strategy (DTS) that allows agents to reach the target tissues
using the shortest physiological routes and with minimal
systemic exposure. In [15], swarms of magneto-aerotactic
bacteria, namely Magnetococcus marinus strain MC-1, are
harnessed for delivering drug-containing nanoliposomes to
the disease site to improve the therapeutic index of various
nanocarriers in tumor regions. MC-1 cells, each containing
a chain of magnetic iron oxide nanocrystals, tend to swim
along local magnetic field lines and towards low oxygen
concentrations based on a two-state aerotactic sensing system.
It was shown that when MC-1 cells were injected near the
tumor and magnetically guided, up to 55% of MC-1 cells
penetrated into hypoxic regions of the tumor. Furthermore,
nanoswimmers assembled by MNPs have also been proposed
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for direct targeting, which use magnetic self-assembly of
50− 100 nm iron oxide nanoparticles [16]. Under an external
magnetic field, the MNPs can magnetize and form chains that
are flexible under time-varying magnetic fields via magneto-
hydrodynamics. A coil system was designed to actuate the
nanoswimmers by applying a nearly uniform magnetic field
through the Helmholtz configuration [17], [18]. One common
external force can control large numbers of nanoswimmers to
perform a complex task such as penetration of a tumor cell
membrane for the selective release of a drug inside the cell
[17], [19]. However, nanoswimmers-assisted direct targeting of
contrast agents requires a priori knowledge about the location
of the disease site, which is usually unavailable if the image
quality is too low in the pre-contrast medical imaging. This
results in a chicken-or-egg dilemma.
3) Amplification of Tumor Homing through Smart Nanosys-
tems: Another strategy to amplify disease targeting is to
design smart nanosystems that leverage the living host envi-
ronment [20]–[29]. These nanosystems can be classified in two
categories: environment-responsive and environment-primed
[24]. The former category encompasses nanoparticles that
sense and subsequently respond to their environment. Altered
in vivo conditions such as redox potential, pH, enzymatic
activity, and homeostatic pathways (see Fig. 1 in [24] for a
comprehensive overview of various mechanisms) induced by
disease conditions can be leveraged to mobilize nanoparticle
systems that are administered in these preexisting contexts.
The latter category is defined by an emerging paradigm of
cooperative nanosystems, such that the host environment is
manipulated by an external influence to enable desired host-
nanoparticle and nanoparticle-nanoparticle interactions, such
as communication, recruitment, or amplification. Modifica-
tions to the host that achieve this primed environment can
be accomplished by administering energy (X-rays, infrared
light, heat), drugs, or nanoparticles themselves. For example,
the nanosystem in [28] consists of two components. The first
component is gold nanorods that populate the porous tumor
vessels via systemic targeting by utilizing the conventional
enhanced permeability and retention (EPR) effect and then
act as photothermal antennas to specify tumor heating via
remote near-infrared laser irradiation. Local tumor heating ac-
celerates the recruitment of the second component: a targeted
nanoparticle consisting of either a prototypical imaging agent
(magnetofluorescent iron oxide nanoworms) or a prototypical
therapeutic agent (doxorubicin-loaded liposomes). In [25],
gold nanorods or engineered proteins target tumors and then
locally activate the coagulation cascade to broadcast tumor lo-
cation to clot-targeted nanoworms or liposomes in circulation.
Smart nanosystems do not require location information of the
disease site. However, they still rely on systemic circulation
for homing to cancer cells without using an external guidance.
B. Biosensing by Learning
The aforementioned experimental investigations provide the
basis for an externally manipulable, smart nanosystem, where
non-manipulable nanoparticles can be replaced by nanoswim-
mers assembled by iron oxide MNPs [16], as depicted in Fig.
Fig. 1. Analogy between (a) DTS employed in an externally manipulable,
smart nanosystem for tumor sensitization, and (b) iterative optimization
process.
1(a). The magnetic response of MNPs, induced by a polarizing
magnetic field, allows for reliable estimation of the locations
of magnetic changes through differential medical imaging
[12], [13]. For environment-responsive operations, an external
controlling and tracking system probes the host environment
by analyzing the measurable characteristics of nanoswimmers
(e.g., trajectories, magnetic changes induced) and steers them
towards the direction where a tumor is likely to be present as
shown in Fig. 1(a). For environment-primed operations, gold
nanorods first prime the host environment [25], [26], [28] to
interact with nanoswimmers. Similarly, the external system
monitors the in vivo responses by observing the properties
of nanoswimmers and maneuver them correspondingly to
enhance tumor sensitization. Should a specific tissue region
be a tumor, MNPs will accumulate in the region on the basis
of the EPR effect or receptor-ligand binding, which can be
observed externally by noticing that MNPs appear to stop
moving [30]–[32].
The current investigation attempts to develop a computa-
tional model for feasibility study of the proposed intelligent
(i.e., knowledge-aided) DTS. Nature’s blueprints have inspired
exciting new fields of science such as bio-inspired computing
that creates problem-solving techniques using insights from
natural systems. For example, the process of natural selection
inspired the development of the classical genetic algorithm to
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solve complex optimization and search problems. It is also
stimulating to look the other way by exploiting computing
strategies for biomedical applications [30], [31]. There is
an intriguing analogy between the knowledge-aided DTS in
an externally manipulable nanosystem for tumor sensitization
(Fig. 1(a)) and the iterative optimization process (Fig. 1(b)).
The global maximum of a unimodal, externally measurable
objective function corresponding to a tumor-induced biophys-
ical phenomenon is the tumor to be detected; the domain of
the function is the tissue region at a high risk of malignancy;
the guess solution is a swarm of externally manoeuvrable
magnetic nanoswimmers. A guess input (i.e., nanoswimmers)
locates the optimal solution (i.e., cancer) by moving through
the domain (i.e., high-risk tissue) under the guidance of a
specified force (i.e., steering field). The objective function may
be altered by the guess made of natural materials because
the guess input interacts with the domain (i.e., nanoswimmers
undergo physical, chemical, and biological interactions with
the host environment). This is in contrast to a traditional
iterative method using a non-interacting approximate solution.
An external observer can then infer the domain by monitoring
the movement of the guess (“seeing-is-sensing” [31]), where
the (n+1)th approximation is derived from the nth one. This
strategy is within the general framework of computing-inspired
bio-detection proposed in our previous work [30]. Provided
with the analogy, a wide variety of iterative methods can thus
be applied to the design of an optimal DTS. To elaborate on
the proposed methodology, the classical gradient descent (GD)
method is used to inspire the DTS, where the guess input
takes steps based on the gradient of the objective function at
the current point. Furthermore, the derivative of the function
needs to be approximated in real-time and the movement of
the guess is constrained by the physical conditions of human
microvasculature.
It is worth noting that, from the computational perspective,
the traditional systemic delivery of contrast agents can be re-
garded as a “brute-force” search where contrast agent nanopar-
ticles attempt to detect a tumor via a medical imaging system
by enumerating all possible pathways in the complex vascular
network and checking whether each pathway is intercepted by
a tumor. Furthermore, the original smart nanosystems in [20]–
[29] can be regarded as a brute-force search given an expanded
tumoral region due to tumor target amplification facilitated
by the peritumoral biophysical conditions (for environment-
responsive nanosystems) or the initial-stage triggering modules
(for environment-primed nanosystems).
C. Organization of the Paper
The paper is organized as follows. In Section II, we discuss
the suitable in vivo biophysical gradients that can be mapped
to externally measurable objective functions. In Section III,
we analyze the propagation model of nanoswimmers in a
discretized capillary network, followed by the discussion on
the general iterative DTS framework and some representative
functions showing different situations that the DTS has to face.
In Section IV, we propose the GD-inspired DTS subject to
the realistic physical constraints of controlling and tracking
nanoswimmers in vivo. In Section V, we provide numerical
examples to demonstrate the effectiveness of the proposed
framework. Finally, some concluding remarks are drawn in
Section VI.
II. EXTERNALLY MEASURABLE OBJECTIVE FUNCTIONS
In the current work, tumor sensitization is performed indi-
rectly through an external controlling and tracking system as
shown in Fig. 1(a), such as an integrated device consisting
of multiple pairs of electromagnetic coils to generate the
rotating magnetic field to actuate the magnetic nanoswimmers
[17], [18] and another coil to supply the polarizing mag-
netic field inducing the magnetic contrast associated with the
nanoswimmers [12], [13]. Therefore, it is necessary that the
in vivo biophysical gradients can be mapped to an externally
measurable objective function by using nanoswimmers as a
probe for analysis of the host environment.
A. Environment-responsive Nanosystems
For this type of nanosystems, passive physical properties of
the host environment such as peritumoral vascular architecture
[33]–[35] and blood flow velocity [34], [36]–[38] can be ex-
ploited to derive the biological gradients. Oxygen and nutrients
are supplied to cancer cells via new blood vessels that have
extended into the cancer tissue. Typical skeletonized images of
various classes of vascular networks demonstrate that normal
capillaries exhibit almost uniformly distributed grid patterns
to ensure adequate oxygen transportation throughout the tissue
[33]–[35]. On the other hand, tumor vessels have a profound
sort of tortuosity with many smaller bends on each larger bend
[33]–[35]. In terms of blood flow velocity, its value in tumor
tissues is significantly lower than that in healthy tissues due to
the hypovascular structure of the malignant lesion [36], [38].
This phenomenon has been observed for cancer cells in the
visceral pleura [37], malignant gliomas [34], and pancreatic
tumors [38]. In summary, the externally measurable objective
functions corresponding to the aforementioned two biophysical
conditions can be derived from the variations in the tortuosity
of nanoswimmer trajectory and the resultant nanoswimmer
velocity, respectively, with respect to the values for normal
tissues. Both of them would increase as the distance between
the nanoswimmer and the tumor decreases.
B. Environment-primed Nanosystems
For this type of systems, specific “activator” nanomaterials
can be used to detect a diseased site and act as tumor-specific
triggers to induce biophysical gradients. For example, gold
nanorods can be modified to circulate for long periods of time
in the blood stream and be passively accumulated in tumors
via systemic circulation [25], [26], [28]. They are used to heat
tumor tissues by amplifying the absorption of near-infrared
energy that is mostly transparent to living tissues [25], [26],
[28]. The associated photothermal heating is highly localized
around the tumor site. Consequently, the gradient of blood flow
velocity is amplified due to the differential response of normal
and tumor microcirculation to hyperthermia, where blood flow
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in normal tissue increases much faster with temperature and
stasis occurs at higher levels of hyperthermia compared to
tumors owning to the rapid growth of tumor cell population
relative to deteriorating vascular beds [39], [40]. Furthermore,
local heating disrupts tumor vessels and initiates extravascular
coagulation. Hence, the fibrin forms the coagulation gradient
centered at the tumor caused by temperature increase. The
magnetic nanoswimmers employ the peptide coatings that
recognize fibrin directly for clot targeting [25], [26], [28].
Direct binding in regions of coagulation will reduce the
concentration of mobile nanoswimmers under tracking. In
summary, the externally measurable objective functions asso-
ciated with the aforementioned two phenomena can be derived
from the variations in the resultant nanoswimmer velocity and
the magnetic contrast induced by nanoswimmers, respectively,
with respect to the values for normal tissues. Both of them
would increase as the distance between the nanoswimmer and
the tumor decreases. In addition, local hyperthermia results
in a temperature gradient from the tissue malignancy to its
peripheral region, which may be directly measured from the
infrared thermographic imaging if the tumor is close to the
skin [25], [26], [28]. In this case, the global gradient towards
the tumor epicenter can be readily obtained.
III. ITERATIVE DTS
A. Invasion-percolation-based Multilayer Vascular Network
Model
Tumor vasculature is more chaotic in appearance than
normal vasculature, which can be measured using fractal
geometries [35]. For example, tumor vessels yield fractal
dimensions of 1.89± 0.04, whereas normal arteries and veins
yield dimensions of 1.70±0.03, and normal capillaries produce
essentially two-dimensional patterns [33]–[35]. It was also
observed that the microvascular density in the peritumoral
region increases due to the supply of growth factors from the
tumor and reduces in the tumor center due to a combination
of severely reduced blood flow and solid stress exerted by the
tumor [41].
Consequently, it is assumed that normal tissues are reg-
ularly vascularized, which results in a homogeneous lattice
comprised of straight, rigid cylindrical capillaries that join
adjacent nodes [34], [42]. On the other hand, the observed
fractal dimensions of tumor vasculature can be described by
the invasion percolation process [33]–[35], which is imple-
mented by first assigning uniformly distributed random values
of strengths to each point on the underlying square lattice
representing potential paths of vascular growth. Starting at an
arbitrary site the network occupies the lattice point adjacent to
the current site that has the lowest strength. Growth is iterated
until the desired lattice occupancy is reached. Blood vessels
are assumed to connect all adjacent occupied lattice points.
Finally, additional edges are added to “pathological” nodes to
ensure nonzero blood flow throughout the entire percolation
cluster. The simulated networks may be matched with real
tumor vasculature by selecting appropriate occupancy levels.
Following [34], the fractal dimensions are around 1.6, 1.8, 1.9,
and 2.0 for 40, 60, 80, and 100% occupancy on the backbone,
respectively.
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Fig. 2. (a) An invasion percolation network after 100 growth steps, and (b)
adding vessels to ensure nonzero blood flow throughout the network.
Fig. 3. Simulated multi-layer vascular network. The level of occupancy on
the lattice reduces from 100% to 40% gradually as the distance to the tumor
center decreases. The boundaries of the layers are denoted by the red solid
lines. The tumor center is denoted by the blue dotted circle.
Moreover, malignant tumors often possess fuzzy and blurred
boundaries [43], [44]. As such, the fractal dimensions across
the boundary of a tumor can be characterized by a smooth
transition from inside a tumor to the outside. To quantify the
diffusive nature of a tissue anomaly, a discretized multilayer
model can be applied to approximate the gradual, continuous
change in the fractal dimension across the periphery of a
lesion. Fig. 2(a) depicts an invasion percolation network after
100 growth steps, and Fig. 2(b) shows additional vessels to
ensure nonzero blood flow throughout the network assuming
that the blood inflow and outflow are in the top left and
bottom right. Fig. 3 illustrates a simulated multilayer vascular
network, where the intercapillary distance is set to be 100 µm,
and the level of occupancy on the lattice reduces from 100%
to 40% gradually as the distance to the tumor center decreases.
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Fig. 4. Time sequence of system operational modes in one cycle for multiple
guess inputs. Each guess has three operational modes: intended actuating (IA),
imaging and tracking (IT), and unintended actuating (UA). Two time-division
multiplexing (TDM) protocols are considered. (a) TDM1: each guess takes
turn to operate in the IA and IT modes; and (b) TDM2: each guess takes turn
to operate in the IA mode, followed by a common IT mode.
B. Problem Formulation
Let f represent an externally measurable objective function
and be defined on the domain D, which denotes the high-
risk tissue region under surveillance. The landscape of f is
distorted by a “natural” guess G representing a swarm of
magnetic nanoswimmers as follows
f (~x;G) = fA (~x;G) + fC (~x;G)
= fT(~x) + fD (~x;G) + fC (~x;G) , ~x ∈ D,
(1)
where fA (~x;G) is the apparent objective function measured
at location ~x through guess G, fT(~x) is the true objective
function at ~x independent of the presence or absence of
G, fD (~x;G) is the disturbance resulted from the interaction
between G and the domain D, and fC (~x;G) is the correction
factor accounting for the disturbance caused by G. For a
meaningful optimization process, it is assumed that regardless
of any variation caused by the guess to the function, the
location of the global maximum denoting the tumor, ~x⋆,
remains unchanged.
The true objective fT(~x), dependent on the underlying
tumor-triggered biophysical phenomena, may take the form
of variation in path tortuosity, velocity, or magnetic contrast
of nanoswimmers as discussed earlier. Subsequently, for the
measure of tortuosity, an alteration fD(~x;G) would incur if
the nanoswimmers are engineered to modify the vasculature
of tumors (e.g., anti-angiogenic agents to shut down tumor ves-
sels or pro-angiogenic agents to normalize tumor vessels) [24].
For the measure of velocity, fD(~x;G) is given by the relative
velocity of nanoswimmers with respect to the blood stream. In
the case of magnetic change, fD(~x;G) is proportional to the
reduction in the concentration of nanoswimmers due to various
loss mechanisms such as degradation (nanoswimmers degen-
erate in the blood), branching (nanoswimmers move into an
unintended vascular branch), and diffusion (random motions
of nanoswimmers driven by the concentration gradient) [45].
Finally, the correction factor fC (~x;G) attempts to counteract
fD (~x;G) to minimize its influence on the true landscape,
i.e., fC (~x;G) = −fD (~x;G) + χ (~x;G) with χ (~x;G) being
the random compensation error. Therefore, Eq. (1) can be
rewritten as
f (~x;G) = fT(~x) + χ (~x;G) , ~x ∈ D. (2)
In the computational framework of DTS, multiple guess
inputs G1, G2, · · · , GN are first deployed in multiple pre-
specified sites R1,R2, · · · ,RN ⊆ D, where Rn (n =
1, 2, · · · , N) denote the injection sites of nanoswimmers as
depicted in Fig. 1. The guesses begin searching for the
optimal solution following some iterative algorithms. The DTS
includes the following key steps.
1) Initialization. The guess inputs are deployed in
R1,R2, · · · ,RN at the same starting times t
(1)
IA,1
as shown in Fig. 4(a)-(b) with initial locations
~x1
(
t
(1)
IA,1
)
, ~x2
(
t
(1)
IA,1
)
, · · · , ~xN
(
t
(1)
IA,1
)
, respectively.
Suppose that the external system operates in the simple
time-multiplexed manner. Without loss of generality,
consider the first guess input G1, which operates on
the following three modes: Intended Actuating (IA),
Imaging and Tracking (IT), and Unintended Actuating
(UA). Two time-division multiplexing (TDM) protocols
are considered. For TDM1 each guess takes turn to
operate in the IA and IT modes, whereas for TDM2 each
guess takes turn to operate in the IA mode, followed by
a common IT mode as illustrated in Fig. 4(a) and 4(b),
respectively.
2) IA. For TDM1, from t
(1)
IA,1 to t
(1)
IT,1, G1 operates in the
IA mode and its trajectory is determined by the angle
deviation relative to a principal axis denoting an intended
steering vector upon G1 at ~x1
(
t
(1)
IA,1
)
, φ
(
t
(1)
IA,1
)
, which
indicates a uniform magnetic field in the surveillance
domain [17], [18] and is dependent on the iterative
method described in Section IV. The next location of G1
at time instant t
(1)
IT,1 is then updated according to:
~x1
(
t
(1)
IT,1
)
= ~x1
(
t
(1)
IA,1
)
+ d1
(
t
(1)
IA,1
)
~u
∠
[
φ
(
t
(1)
IA,1
)
+∆φ
(
t
(1)
IA,1
)]
+ ~q1
(
t
(1)
IA,1
)
.
(3)
The term ~u∠φ denotes a unit vector with angle φ and
∆φ
(
t
(1)
IA,1
)
is a random variable summarizing all steering
imperfections, which is assumed to be normally dis-
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Fig. 5. Updating of a guess input in the taxicab vascular network subject to
a specified steering vector.
tributed with variance σ2∆φ and zero mean for simplicity.
The displacement length d1
(
t
(1)
IA,1
)
satisfies
∥∥∥∥d1
(
t
(1)
IA,1
)
~u
∠
[
φ
(
t
(1)
IA,1
)
+∆φ
(
t
(1)
IA,1
)]
∥∥∥∥
1
=
∣∣∣∣d1
(
t
(1)
IA,1
)
cos
[
φ
(
t
(1)
IA,1
)
+∆φ
(
t
(1)
IA,1
)] ∣∣∣∣
+
∣∣∣∣d1
(
t
(1)
IA,1
)
sin
[
φ
(
t
(1)
IA,1
)
+∆φ
(
t
(1)
IA,1
)] ∣∣∣∣
= v1
(
t
(1)
IA,1
)(
t
(1)
IT,1 − t
(1)
IA,1
)
,
(4)
where ‖ · ‖1 denotes the ℓ1 norm and v1
(
t
(1)
IA,1
)
is the
velocity of G1 at t
(1)
IA,1 given the taxicab geometry of
the vascular network. Finally, ~q1
(
t
(1)
IA,1
)
is the position
“quantization” error due to the discrete lattice pattern
of the vasculature as illustrated in Fig. 5, which is
the displacement vector from the point ~x1
(
t
(1)
IA,1
)
+
d1
(
t
(1)
IA,1
)
~u
∠
[
φ
(
t
(1)
IA,1
)
+∆φ
(
t
(1)
IA,1
)] on the continuous
taxicab circle of radius v1
(
t
(1)
IA,1
)(
t
(1)
IT,1 − t
(1)
IA,1
)
, to its
closest point in the discrete vascular network having the
same taxicab distance to ~x1
(
t
(1)
IA,1
)
.
For TDM2, the same process as mentioned above applies
except that t
(1)
IT,1 is replaced by t
(1)
IA,2 as shown in Fig.
4(b).
3) IT. For TDM1, from t
(1)
IT,1 to t
(1)
IA,2, G1 operates in the
IT mode. In the absence of a steering field, G1 follows a
random walk in the lattice (i.e., at each intersection it has
the same probability to either move up or to the right)
and swims towards various locations in equal observa-
tion time intervals along a zigzag pathway, ~x1
(
t
(1)
IT,1
)
,
~x1
(
t
(1)
IT,1 +∆t
)
, · · · , ~x1
(
t
(1)
IT,1 +K∆t
)
, ~x1
(
t
(1)
IA,2
)
as
shown in Fig. 6, where ∆t =
(
t
(1)
IA,2 − t
(1)
IT,1
)
/(K + 1).
Various imaging modalities such as MRI [1] and mi-
crowave imaging [12] can be used to detect the magnetic
contrast induced by multiple magnetic nanoswimmers
simultaneously, which allows for tracking of all the
nanoswimmers. In contrast to mathematical computing
where the location of a guess input is known exactly, the
guess location in the current “natural” computing needs
to be estimated. The positioning error is summarized
in the random variable ∆~x1 as also shown in Fig. 6,
whose horizontal and vertical components are assumed
to be independently and identically distributed Gaussian
random variables with equal variance σ2∆x and zero mean
for simplicity. In that case, |∆~x1| is Rayleigh-distributed.
The objective function is then evaluated at each location.
For example, if the nanoswimmer velocity is considered,
the values are obtained as
f
(
~x1
(
t
(1)
IT,1 + k∆t
)
+∆~x1
(
t
(1)
IT,1 + k∆t
))
≈
1
∆t
∥∥∥~x1
(
t
(1)
IT,1 + (k + 1)∆t
)
+∆~x1
(
t
(1)
IT,1 + (k + 1)∆t
)
− ~x1
(
t
(1)
IT,1 + k∆t
)
−∆~x1
(
t
(1)
IT,1 + k∆t
) ∥∥∥
1
, k = 0, 1, · · · ,K.
(5)
Subsequently, the gradient for guess G1 at t
(1)
IT,1 is esti-
mated as follows
∇f
(
~x1
(
t
(1)
IT,1
))
≈ max
k1,k2{[
f
(
~x1
(
t
(1)
IT,1 + k1∆t
)
+∆~x1
(
t
(1)
IT,1 + k1∆t
))
− f
(
~x1
(
t
(1)
IT,1 + k2∆t
)
+∆~x1
(
t
(1)
IT,1 + k2∆t
)) ]/
∥∥∥~x1
(
t
(1)
IT,1 + k1∆t
)
+∆~x1
(
t
(1)
IT,1 + k1∆t
)
− ~x1
(
t
(1)
IT,1 + k2∆t
)
−∆~x1
(
t
(1)
IT,1 + k2∆t
)∥∥∥
2
}
,
k1 > k2 and k1, k2 ∈ {0, 1, · · · ,K},
(6)
where ‖ ·‖2 is the ℓ2 norm. The overall gradient after N
IT processes is estimated by taking into account all the N
gradients obtained at t
(1)
IT,1, t
(1)
IT,2, · · · , t
(1)
IT,N , respectively.
A new steering vector for G1 is then computed by
following a specified algorithm as discussed in Section
IV, which is used to guide the movement of G1 during
the next IA operation at t
(2)
IA,1 as shown in Fig. 4(a). As
the nanoswimmer is in the form of nanochains or bundle-
like aggregates assembled by MNPs [16], it has a finite
lifespan due to the dissembling and diffusion of MNPs
during propagation. In the case that G1 is fully consumed
in D, a new guess input is deployed at R.
For TDM2, G1 operates in the UA mode (as explained
below) from t
(1)
IA,2 to t
(1)
IA,3 when G2 is in the IA mode.
4) UA. For TDM1, from t
(1)
IA,2 to t
(1)
IT,2, G1 operates in the
UA mode. This is similar to the IA operation except
that the steering field is meant for the second guess G2.
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Fig. 6. Pictorial illustration of the IT process: the guess follows a random walk
in the lattice and moves towards various locations along a zigzag pathway,
~x1
(
tIT,1
)
, ~x1
(
tIT,1 +∆t
)
, · · · , ~x1
(
tIT,1 +K∆t
)
, ~x1
(
tIA,2
)
with ∆t
being the observation time interval.
This is due to the limitation of the current coil system
in generating the steering field, which exerts a global
uniform torque on all the nanoswimmers simultaneously
instead of localized torques on individual nanoswimmers.
The same DTS steps (i.e., IA→ IT → UA) are applied
to all the guesses in sequence and the iteration continues
unless certain stopping criteria are met.
For TDM2, from t
(1)
IA,3 to t
(1)
IA,4, G1 again operates in the
UA mode when G3 is now in the IA mode. The next IT
operation only occurs after all the guess inputs complete
their individual IA operations. This will be followed by
a new round of IA → UA → IT operations starting at
t
(2)
IA,1 as shown in Fig. 4(b).
The mapping from an iterative optimization process in math-
ematical computing to the aforementioned tumor sensitization
process in natural computing is illustrated in Fig. 7, which
encompasses the following procedures.
1) General Mapping. Formulate the nanoswimmers-assisted
tumor sensitization in the perspective of natural comput-
ing as a stylized representation of the iterative optimiza-
tion problem in mathematical computing.
2) Specific Mapping. Consider a specific iterative optimiza-
tion algorithm A, which is the GD in the current work,
and map A onto the corresponding DTS S. For example,
the key operations in a standard GD include taking the
step, finding the gradient, and evaluating the objective
function. The first operation corresponds to the IA mode
in the DTS and the last two operations are associated
with the IT mode in the DTS.
3) Reality Check. Identify the key physical constraints as-
sociated with S when applied in a realistic in vivo
environment, compared to the original algorithm A when
Fig. 7. Mapping from iterative optimization in mathematical computing to
tumor sensitization in natural computing.
applied in an idealistic mathematical setting. For example,
the imperfections in DTS include the landscape mismatch
χ (~x;G) in Eq. (2), the steering imperfection ∆φ
(
t
(1)
IA,1
)
and the landscape quantization noise ~q1
(
t
(1)
IA,1
)
in Eq.
(3), the finite velocity of guess v1
(
t
(1)
IA,1
)
in Eq. (4),
the positioning error ∆~x1
(
t
(1)
IT,1 + (k + 1)∆t
)
and the
gradient estimation inaccuracy in Eq. (5), the interference
in guess update caused by UA, and the finite lifespan of
guess inputs.
4) Performance Benchmarking. From the tumor sensitization
perspective, we can evaluate the performance of the DTS
S by comparing S to the “brute-force” systemic target-
ing without implementing any knowledge-aided targeting
strategy. From the iterative optimization perspective, we
can compare S to the standard algorithm A. In this case,
S is regarded as a degenerate form of A.
C. Representative Objective Functions
As the research is in its early stage, there is no widely-
accepted, quantitative model on any of the aforementioned
biophysical gradients in the existing literature other than some
qualitative observations made from experimental data. As an
initial investigation, three representative objective functions
are considered to evaluate the performance of the externally
manipulable, smart nanosystems for enhanced tumor sensiti-
zation as shown in Fig. 8. The maximum value is normalized
to 1 and the minimum value is 0. The search domain is
−5 mm ≤ x, y ≤ 5 mm. The landscapes are:
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1) Sphere Function (Bowl-shaped):
f(x, y) =

1,
√
x2 + y2 ≤ 0.5 and (x, y) ∈ V
1− 0.02
(
x2 + y2
)
,√
x2 + y2 > 0.5 and (x, y) ∈ V.
(7)
Fig. 8. Illustration of f(x, y) for three representative objective functions:
(a) Sphere function and (b) its contour plot; (c) Matyas function and (d) its
contour plot; (e) Easom function and (f) its contour plot. For the objective
f(x, y), the maximum is normalized to 1 and the minimum value is 0.
2) Matyas Function (Plate-shaped):
f(x, y) =

1,
√
x2 + y2 ≤ 0.5 and (x, y) ∈ V
1− 0.01
(
x2 + y2
)
+ 0.02xy,√
x2 + y2 > 0.5 and (x, y) ∈ V.
(8)
3) Easom function:
f (x, y) =

1,
√
x2 + y2 ≤ 0.5 and (x, y) ∈ V
0.01 + 0.99 cos(3x) cos(3y)
× exp
[
−
(
9x2 + 9y2
)]
,√
x2 + y2 > 0.5 and (x, y) ∈ V.
(9)
The term V denotes the discrete vascular network as illustrated
in Fig. 3. As shown in Fig. 8(a)-(b), both the Sphere and
Matyas functions represent the situation that the tumor center,
denoted by a circle of radius 0.5 mm located at the origin, is
associated with the region having the highest values of f(x, y).
This may correspond to the largest (normalized) variation of
blood flow velocity due to tumor angiogenesis or the largest
(normalized) magnetic change induced by nanoswimmers due
to fibrin tropism in tumor tissues. Both the functions are
convex and quadratic. They have no local minimum except
the global one. On the other hand, the Easom function in
Fig. 8(c) represents the situation that f(x, y) remains more or
less unchanged across a large surveillance region. The tumor
center yields an abrupt increase of f(x, y). Intuitively, this
may represent the worst-case direct targeting scenario due to
the lack of an externally observable biophysical gradient.
In the absence of detailed information on the diameters
of vessels, the viscosity of blood, and the applied blood
pressure for tumor vessels and normal capillaries near the
tumor, we simply imprint the objective functions in (7)-(9)
on the vascular network V. The blood inflow and outflow are
assumed to be in the bottom left and top right, respectively,
where prescribed pressures are set.
IV. GD-INSPIRED DTS
The GD-inspired DTS starts with a generic guessG1 located
at ~x1 at time instant t
(1)
IA,1, which attempts to find a global
maximum f (~x∗).
A. DTS for TDM1
For TDM1 shown in Fig. 4(a), consider the
sequence ~x1
(
t
(1)
IT,1
)
, ~x1
(
t
(2)
IT,1
)
, ~x1
(
t
(3)
IT,1
)
, · · · . In
the classical GD, ~x1
(
t
(m)
IT,1
)
= ~x1
(
t
(m−1)
IT,1
)
+
γm−1∇f
(
~x1
(
t
(m−1)
IT,1
))
,m = 2, 3, · · · . In this way, we have
f
(
~x1
(
t
(1)
IT,1
))
≤ f
(
~x1
(
t
(2)
IT,1
))
≤ f
(
~x1
(
t
(3)
IT,1
))
≤ · · · ,
so hopefully the sequence ~x1
(
t
(m)
IT,1
)
converges to the desired
global maximum. However, in the GD-inspired DTS, the
location updating is interrupted by multiple IT and UA
processes as depicted in Fig. 4(a). Hence, the position update
is modified as ~x1
(
t
(m)
IT,1
)
= ~x1
(
t
(m)
IA,1
)
+γm∇f
(
~x1
(
t
(m)
IA,1
))
.
The gradient ∇f
(
~x1
(
t
(m)
IA,1
))
is estimated through the N
IT processes as illustrated in Fig. 4(a). If the gradient does
not change much over the duration of t
(m)
IT,1 to t
(m+1)
IT,1 , it can
be estimated as
∇f
(
~x1
(
t
(m)
IA,1
))
≈ max
n=1,2,··· ,N
{
∇f
(
~x1
(
t
(m)
IT,n
))}
. (10)
Otherwise, only the last gradient estimate is used such that
∇f
(
~x1
(
t
(m)
IA,1
))
≈ ∇f
(
~x1
(
t
(m)
IT,N
))
. (11)
Suppose that f (~x) is convex and ∇f (~x) is Lipschitz, the step
size γm can be chosen to guarantee convergence to a global
optimum by using the Barzilai-Borwein method [46]:
γm ≈
(
~x1
(
t
(m)
IA,1
)
− ~x1
(
t
(m−1)
IA,1
))T
∥∥∥∇f (~x1
(
t
(m)
IA,1
))
−∇f
(
~x1
(
t
(m−1)
IA,1
))∥∥∥2
×
[
∇f
(
~x1
(
t
(m)
IA,1
))
−∇f
(
~x1
(
t
(m−1)
IA,1
))]
.
(12)
Note that the vessel network used in the simulation pro-
cedure is a discontinuous two-dimensional grid as shown in
Fig. 3; therefore the position update follows the procedure
described in Section III-B. As the vessels run only parallel to
the two coordinate axes, at each junction the guess input can
move in two possible directions, up and right, as the flow is
from bottom left to top right. The Barzilai-Borwein condition
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in (12) is employed to determine the duration of the mth IA
operation for G1:
t
(m)
IT,1 − t
(m)
IA,1 =
γm cosφm + γm sinφm
v1
(
t
(m)
IA,1
) , (13)
where φm is the angle of the gradient estimated at the m
th
cycle.
B. DTS for TDM2
For TDM2 shown in Fig. 4(b), similarly, consider
the sequence ~x1
(
t
(1)
IA,2
)
, ~x1
(
t
(2)
IA,2
)
, ~x1
(
t
(3)
IA,2
)
, · · · .
In the classical GD, ~x1
(
t
(m)
IA,2
)
= ~x1
(
t
(m−1)
IA,2
)
+
γm−1∇f
(
~x1
(
t
(m−1)
IA,2
))
,m = 2, 3, · · · , to ensure that
the sequence ~x1
(
t
(m)
IA,2
)
converges to the desired global
maximum. However, in the GD-inspired DTS, the location
updating is interrupted by multiple UA processes and one IT
process as depicted in Fig. 4(b). Hence, the position update is
expressed as ~x1
(
t
(m)
IA,2
)
= ~x1
(
t
(m)
IA,1
)
+ γm∇f
(
~x1
(
t
(m)
IA,1
))
.
To ensure that such an arrangement does not favor IA
processes that are closer to the earlier IT operation resulted
from more accurate gradient estimation, the gradient change
over the duration of t
(m−1)
IA,1 to t
(m)
IA,1 should be minimal, which
is approximated by
∇f
(
~x1
(
t
(m)
IA,1
))
≈ ∇f
(
~x1
(
t
(m−1)
IT
))
, (14)
where ∇f
(
~x1
(
t
(m−1)
IT
))
is the gradient estimated during the
(m− 1)th IT process.
Finally, due to the practical constraint of DTS, the initial
deployment region of the guess input is confined within a small
area, which is the injection site of nanoswimmers, instead of
the entire solution space. To further ensure that the guess
input is confined within the tissue region under screening,
the replacement strategy is implemented: a guess that travels
outside the allowed searching region is abandoned, which will
degrade in the human body without further maneuvering and
tracking. A new guess is then generated in the deployment
area by injecting an aggregate of nanoswimmers.
V. PERFORMANCE ANALYSIS
We use several numerical examples to evaluate the tumor
sensitization and targeting performance of the GD-inspired
DTS, which is compared to the brute-force search.
For the DTS, both the two protocols in Fig. 4 are considered
where two guess inputs are deployed for direct targeting. The
durations of IA and IT are set to be 10 s and the number of
observation intervals during each IT operation (see also Fig.
6) is 10. The searching process is stopped if any guess reaches
the cancer center denoted by a circle of radius 0.5 mm at the
origin as shown in Fig. 8. It is assumed that the other guess
can be guided to the tumor center upon successful detection
if it has not overshot the tumor location.
For the brute-force search, each guess follows a random
walk without learning from the environment, which synthe-
sizes the contrast-enhanced medical imaging scenario where
-5 0 5
[mm]
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0
5
[m
m]
Brute-force
Gradient descent
Tumor center
Fig. 9. Trajectories of guess inputs when TDM1 is applied: “◦” - GD-inspired
DTS, “” - brute-force search.
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Fig. 10. Trajectories of guess inputs when TDM2 is applied: “◦” - GD-
inspired DTS, “” - brute-force search.
contrast agent nanoparticles attempt to target a tumor by
enumerating all possible pathways in the vascular network.
For consistency with the GD-inspired DTS, the trajectories of
two guess inputs are displayed. Furthermore, the random drift
and IT durations follow the two protocols in Fig. 4, though the
movement of these two guesses are completely independent
of each other. The searching process is stopped if any guess
reaches the cancer center as in the case of DTS. However, the
other guess will continue its random drift in the absence of an
external guidance.
The three objective functions presented in Section III-C are
applied to synthesize different levels of tumor sensitization
difficulty. The initial deployment region is −5 mm ≤ x, y ≤
−4 mm. The speed of nanoswimmers is 100 µm/s. The
maximum search time allowed is 200 s and the total number
of simulation runs is 1000. Two performance metrics are
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considered, the probability of cancer detection PD and the
percentage of contrast agent nanoparticles delivered to the
tumor site η.
Fig. 9 shows the typical trajectories of guess inputs for
the landscape of Sphere function when the TDM1 protocol
is considered. The symbols of “◦” and “” denote the actual
guess footprints for the GD-inspired DTS and brute-force
search, respectively, and regions with clustered footprints
correspond to the IA mode. As can be seen from the figure, in
the case of DTS the movement of both guesses is coordinated
by an external field towards the maximum-gradient direction
estimated in the IA mode. On the other hand, the movement
of two guesses is irregular and uncorrelated for the brute-
force search. The DTS successfully detects the tumor center,
whereas the brute-force search technique fails to find the
center of tissue malignancy even with multiple guesses. Fig.
10 presents the guess trajectories when the TDM2 protocol is
applied. The time interval between two consecutive IAs for
TDM2 is twice of the value for TDM1 because in the former
case, each guess takes turn to operate in the IA mode, followed
by a common IT mode. Hence, the gradient estimated during
the IT operation may be different from the actual gradient
for the later IA process, leading to more departing trajectories
of the guesses as depicted in Fig. 10. It is expected that this
phenomenon would result in deteriorating tumor sensitization
and targeting performance. Similar observations were made
for the Matyas and Easom landscapes.
Fig. 11 presents the histograms of search time for the three
objective functions when the TDM1 protocol is employed. The
search time of 200 s (maximum value) indicates the situation
that none of the two guesses senses the tumor. It can be
seen that the GD-inspired DTS yields a detection ratio of
PD = 89.6% for the Sphere function (Fig. 11(a)), which is
much higher than that for the brute-force search (PD = 58.1%,
Fig. 11(b)). Furthermore, the DTS has better performance
in the Sphere landscape than the Matyas (PD = 73.0%,
Fig. 11(c)) and Easom (PD = 59.8%, Fig. 11(e)) functions.
This observation demonstrates the advantage of the proposed
biosensing-by-learning strategy over brute-force search and the
potential performance deterioration due to a more complex
landscape (i.e., plate-shaped Matyas function and gradientless
Easom function versus bowl-shaped Sphere function). In terms
of the targeting efficiency, the DTS achieves a much higher
value of η = 78.0% compared to that for the Matyas
(η = 61.6%) and Easom (η = 49.0%) functions as well as
the brute-force search (η ≈ 32%).
Fig. 12 presents the histograms of search time for TDM2.
Similar observations to the trend in Fig. 11 can be made.
Furthermore, comparing Fig. 12 to Fig. 11 shows that, TDM1
yields higher probabilities of tumor sensitization and larger
percentages of drug molecules delivered to the tumor than
TDM2.
VI. CONCLUSION
We have proposed a novel iterative-optimization-inspired
DTS in externally manipulable smart nanosystems, which
exploits tumor-triggered in vivo biophysical gradients for
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Fig. 11. Histograms of search time when TDM1 is applied: (a) GD-inspired
DTS and (b) brute-force search in a Sphere landscape; (c) GD-inspired DTS
and (d) brute-force search in a Matyas landscape; (c) GD-inspired DTS and
(d) brute-force search in an Easom landscape. Also shown are the respective
detection ratios PD and targeting efficiencies η.
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Fig. 12. Histograms of search time when TDM2 is applied: (a) GD-inspired
DTS and (b) brute-force search in a Sphere landscape; (c) GD-inspired DTS
and (d) brute-force search in a Matyas landscape; (c) GD-inspired DTS and
(d) brute-force search in an Easom landscape. Also shown are the respective
detection ratios PD and targeting efficiencies η.
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“guided” direct targeting. We have demonstrated through
computational experiments that the proposed DTS can signif-
icantly improve the probability of tumor sensitization and the
accumulation of drug nanoparticles in the tumor site by using
the shortest possible physiological routes and with minimal
systemic exposure. We believe that this work motivates a
new paradigm directed toward smart biosensing facilitated by
externally controllable nanoswimmers.
Future work may include extension of the framework to
DTS inspired by multi-solution or multi-objective optimiza-
tions when there are multiple tumors or different phenomena-
of-interest in the tissue region under surveillance. Moreover,
it is important to examine further the impact of nanoswimmer
nonidealities, such as finite lifespan, imprecise steering, and
inaccurate tracking. Finally, the proposed DTS and the objec-
tive functions used should be validated by real experiments to
justify further the clinical relevance of the proposed strategy.
REFERENCES
[1] S. Thoidingjam and A. B. Tiku, “New developments in breast cancer
therapy: role of iron oxide nanoparticles,” Adv. Nat. Sci.: Nanosci.
Nanotechnol., vol. 8, pp. 023002, 2017.
[2] A. Modiri, S. Goudreau, A. Rahimi, and K. Kiasaleh, “Review of breast
screening: Toward clinical realization of microwave imaging,” Med.
Phys., vol. 44, no. 12, pp. e446–e458, 2017.
[3] F. Yang, L. Sun, Z. Hu, H. Wang, D. Pan, R. Wu, X. Zhang, Y. Chen,
and Q. Zhang, “A large-scale clinical trial of radar-based microwave
breast imaging for Asian women: Phase I,” in Proc. IEEE IEEE AP-
S Symposium on Antennas and Propagation and USNC-URSI Radio
Science Meeting 2017, San Diego, USA, July 2017.
[4] H. Song, S. Sasada, T. Kadoya, M. Okada, K. Arihiro, X. Xiao, and
T. Kikkawa, “Detectability of breast tumor by a hand-held impulse-
radar detector: Performance evaluation and pilot clinical study,” Sci.
Rep., vol. 7, no. 1, pp. 16353, 2017.
[5] E. Porter, M. Coates, and M. Popovic´, “An early clinical study of time-
domain microwave radar for breast health monitoring,” IEEE Trans.
Biomed. Eng., vol. 63, no. 3, pp. 530–539, 2016.
[6] A. W. Preece, I. Craddock, M. Shere, L. Jones, and H. L. Winton,
“MARIA M4: Clinical evaluation of a prototype ultrawideband radar
scanner for breast cancer detection,” J. Med. Imag., vol. 3, no. 3, pp.
033502, 2016.
[7] P. M. Meaney, P. A. Kaufman, L. S. Muffly, M. Click, S. P. Poplack,
W. A. Wells, G. N. Schwartz, R. M. di Florio-Alexander, T. D. Tosteson,
Z. Li, S. D. Geimer, M. W. Fanning, T. Zhou, N. R. Epstein, and
K. D. Paulsen, “Microwave imaging for neoadjuvant chemotherapy
monitoring: Initial clinical experience,” Breast Cancer Res., vol. 15,
no. 2, pp. 1–16, 2013.
[8] D. O’Loughlin, M. J. O’Halloran, B. M. Moloney, M. Glavin, E. Jones,
and M. A. Elahi, “Microwave breast imaging: Clinical advances and
remaining challenges,” IEEE Trans. Biomed. Eng., 2018, Early Access,
DOI: 10.1109/TBME.2018.2809541.
[9] M. Lazebnik, D. Popovic, L. McCartney, C. B.Watkins, M. J. Lindstrom,
J. Harter, S. Sewall, T. Ogilvie, A. Magliocco, T. M. Breslin, W. Temple,
D. Mew, J. H. Booske, M. Okoniewski, and S. C. Hagness, “A
large-scale study of the ultrawideband microwave dielectric properties
of normal, benign and malignant breast tissues obtained from cancer
surgeries,” Phys. Med. Biol., vol. 52, pp. 6093–6115, 2007.
[10] A. P. O’Rourke, M. Lazebnik, J. M. Bertram, and et al., “Dielectric
properties of human normal, malignant and cirrhotic liver tissue: in vivo
and ex vivo measurements from 0.5 to 20 GHz using a precision open-
ended coaxial probe,” Phys. Med. Biol., vol. 52, pp. 4707–4719, 2007.
[11] S. Semenov, “Microwave tomography: Review of the progress towards
clinical applications,” Phil. Trans. R. Soc. A, vol. 367, pp. 3021–3042,
2009.
[12] O. M. Bucci, G. Bellizzi, A. Borgia, S. Costanzo, L. Crocco, G. Di
Massa, and R. Scapaticci, “Experimental framework for magnetic
nanoparticles enhanced breast cancer microwave imaging,” IEEE Access,
vol. 5, pp. 16332–16340, 2017.
[13] O. M. Bucci, L. Crocco, and R. Scapaticci, “On the optimal measure-
ment configuration for magnetic nanoparticles-enhanced breast cancer
microwave imaging,” IEEE Trans. Biomed. Eng., vol. 62, no. 2, pp.
407–414, 2015.
[14] Y. H. Bae and K. Park, “Targeted drug delivery to tumors: Myths, reality
and possibility,” J. Con. Rel., vol. 153, pp. 198–205, 2011.
[15] O. Felfoul, M. Mohammadi, S. Taherkhani, and et al., “Magneto-
aerotactic bacteria deliver drug-containing nanoliposomes to tumour
hypoxic regions,” Nature Nanotechnology, vol. 11, pp. 941–947, 2016.
[16] U. K. Cheang and M. J. Kim, “Self-assembly of robotic micro- and
nanoswimmers using magnetic nanoparticles,” J. Nanopart. Res., vol.
17, no. 145, 2015.
[17] U. K. Cheang, F. Meshkati, H. Kim, K. Lee, H. C. Fu, and M. J. Kim,
“Versatile microrobotics using simple modular subunits,” Sci. Rep., vol.
6, no. 30472, 2016.
[18] U. K. Cheang, H. Kim, D. Milutinovic´, J. Choi, and M. J. Kim,
“Feedback control of robotic achiral microswimmers,” J. Bionic. Eng.,
vol. 14, no. 2, pp. 245–259, 2017.
[19] L. Mertz, “Tiny conveyance: Micro- and nanorobots prepare to advance
medicine,” IEEE Pulse, vol. 9, no. 1, pp. 19–23, 2018.
[20] K. Seidi, H. A. Neubauer, R. Moriggl, and R. Jahanban-Esfahlan, “Tu-
mor target amplification: Implications for nano drug delivery systems,”
J. Con. Rel., vol. 275, pp. 142–161, 2018.
[21] M. Overchuk and G. Zheng, “Overcoming obstacles in the tumor
microenvironment: Recent advancements in nanoparticle delivery for
cancer theranostics,” Biomaterials, vol. 156, pp. 217–237, 2018.
[22] H. Kim, J. Lee, C. Oh, and J.-H. Park, “Cooperative tumour cell
membrane targeted phototherapy,” Nat. Commun., vol. 8, no. 15880,
pp. 1–10, 2017.
[23] B. Zhang, H. Wang, S. Shen, X. She, W. Shi, J. Chen, Q. Zhang,
Y. Hu, Z. Pang, and X. Jiang, “Fibrin-targeting peptide creka-conjugated
multi-walled carbon nanotubes for self-amplified photothermal therapy
of tumor,” Biomaterials, vol. 79, pp. 46–55, 2016.
[24] E. J. Kwon, J. H. Lo, and S. N. Bhatia, “Smart nanosystems: Bio-
inspired technologies that interact with the host environment,” Proc.
Natl. Acad. Sci. U. S. A., vol. 112, no. 47, pp. 14460–14466, 2015.
[25] G. von Maltzahn, J.-H. Park, K. Y. Lin, N. Singh, C. Schwo¨ppe,
R. Mesters, W. E. Berdel, E. Ruoslahti, M. J. Sailor, and S. N. Bhatia,
“Nanoparticles that communicate in vivo to amplify tumour targeting,”
Nat. Mater., vol. 10, pp. 545–552, 2011.
[26] J.-H. Park, G. von Maltzahn, L. L. Ong, A Centrone, T. A. Hatton,
E. Ruoslahti, S. N. Bhatia, and M. J. Sailor, “Cooperative nanoparticles
for tumor detection and photothermally triggered drug delivery,” Adv.
Mater., vol. 22, pp. 880–885, 2010.
[27] L. Agemy, K. N. Sugahara, V. R. Kotamraju, K. Gujraty, O. M.
Girard, Y. Kono, R. F. Mattrey, J.-H. Park, M. J. Sailor, A. I. Jimenez,
C. Cativiela, D. Zanuy, F. J. Sayago, C. Aleman, R. Nussinov, and E. Ru-
oslahti, “Nanoparticle-induced vascular blockade in human prostate
cancer,” Blood, vol. 116, pp. 2847–2856, 2010.
[28] J.-H. Park, G. von Maltzahnc, M. J. Xu, V. Fogald, V. R. Kotamraju,
E. Ruoslahti, S. N. Bhatia, and M. J. Sailor, “Cooperative nanomaterial
system to sensitize, target, and treat tumors,” Proc. Natl. Acad. Sci. U.
S. A., vol. 107, no. 3, pp. 981–986, 2010.
[29] D. Simberg, T. Duza, J.-H. Park, M. Essler, J. Pilch, L. Zhang, A. M.
Derfus, M. Yang, R. M. Hoffman, S. Bhatia, M. J. Sailor, and E. Ru-
oslahti, “Biomimetic amplification of nanoparticle homing to tumors,”
Proc. Natl. Acad. Sci. U. S. A., vol. 104, no. 3, pp. 932–936, 2007.
[30] Y. Chen, S. Shi, X. Yao, and T. Nakano, “Touchable computing:
Computing-inspired bio-detection,” IEEE Trans. Nanobiosci., vol. 16,
no. 8, pp. 810–821, 2017.
[31] Y. Chen, T. Nakano, P. Kosmas, C. Yuen, A. V. Vasilakos, and M. Asvial,
“Green touchable nanorobotic sensor networks,” IEEE Commun. Mag.,
pp. 136–142, Nov. 2016.
[32] Y. Chen, P. Kosmas, and S. Martel, “A feasibility study for microwave
breast cancer detection using contrast-agent-loaded bacterial microbots,”
Int. J. Antennas Propag., vol. 2013, Article ID 309703, 11 pages,
http://dx.doi.org/10.1155/2013/309703.
[33] Y. Gazit, D. A. Berk, M. Leunig, L. T. Baxter, and R. K. Jain, “Scale-
invariant behavior and vascular network formation in normal and tumor
tissue,” Phys. Rev. Lett., vol. 75, no. 12, pp. 2428–2431, 1995.
[34] J. W. Baish, Y. Gazit, D. A. Berk, M. Nozue, L. T. Baxter, and R. K.
Jain, “Role of tumor vascular architecture in nutrient and drug delivery:
An invasion percolation-based network model,” Microvasc. Res., vol.
51, pp. 327–346, 1996.
[35] J. W. Baish and R. K. Jain, “Fractals and cancer,” Cancer Res., vol.
60, pp. 3683–3688, 2000.
SUBMITTED TO IEEE TRANSACTIONS ON NANOBIOSCIENCE 12
[36] D. Fukumura and R. K. Jain, “Tumor microvasculature and microenvi-
ronment: targets for anti-angiogenesis and normalization,” Microvasc.
Res., vol. 74, pp. 72–84, 2007.
[37] Y. Wang, K. Iguchi, H. Ito, K. Ookawa, N. Kobayashi, R. Nakamura,
Y. Goto, M. Sakai, S. Ishikawa, and M. Onizuka, “Blood flow velocity
is reduced in a tumor micro-dissemination in the visceral pleura in
anesthetized open-chest rat lung,” In Vivo, vol. 23, pp. 291–296, 2009.
[38] G. Komar, S. Kauhanen, K. Liukko, M. Seppanen, S. Kajander,
J. Ovaska, P. Nuutila, and H. Minn, “Decreased blood flow with
increased metabolic activity: A novel sign of pancreatic tumor aggres-
siveness,” Clin. Cancer Res., vol. 15, no. 17, pp. 5511–5517, 2009.
[39] T. E. Dudar and R. K. Jain, “Differential response of normal and tumor
microcirculation to hyperthermia,” Cancer Res., vol. 44, pp. 605–612,
1984.
[40] C. W. Song, “Effect of local hyperthermia on blood flow and microen-
vironment: A review,” Cancer Res. (Suppl.), vol. 44, pp. 4721s–4730s,
1984.
[41] D.-S. Lee, H. Rieger, and K. Bartha, “Flow correlated percolation during
vascular remodeling in growing tumors,” Phys. Rev. Lett., vol. 96, no.
058104, 2006.
[42] S. R. McDougall, A. R. A. Anderson, and M. A. J. Chaplain, “Math-
ematical modelling of flow through vascular networks: Implications for
tumor-induced angiogenesis and chemotherapy strategies,” Bull. Math.
Biol., vol. 64, pp. 673–702, 2002.
[43] R. M. Rangayyan, N. M. El-Faramawy, J. E. Leo Desautels, and O. A.
Alim, “Measures of acutance and shape for classification of breast
tumors,” IEEE Trans. Med. Imag., vol. 16, no. 6, pp. 799–810, 1997.
[44] R. Saunders, E. Samei, J. Baker, and D. Delong, “Simulation of
mammographic lesions,” Academic Radiology, vol. 13, no. 7, pp. 860–
870, 2006.
[45] Y. Chen, P. Kosmas, P. S. Anwar, and L. Huang, “A touch-
communication framework for drug delivery based on a transient mi-
crobot system,” IEEE Trans. Nanobiosci., vol. 14, no. 4, pp. 397–408,
June 2015.
[46] J. Barzilai and J. M. Borwein, “Two-point step size gradient methods,”
IMA Journal of Numerical Analysis, vol. 8, no. 1, pp. 141–148, 1988.
